Glucose Health, Inc. (GLUC) stock
GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)
Close on Oct 19, 2026Market cap $1.82MP/E –Yield –
Glucose Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Glucose Health
Glucose Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?